For: | Wang FS, Xing LH, Liu MX, Zhu CL, Liu HG, Wang HF, Lei ZY. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 2001; 7(4): 537-541 [PMID: 11819824 DOI: 10.3748/wjg.v7.i4.537] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i4/537.htm |
Number | Citing Articles |
1 |
Morikazu ONJI. Role of dendritic cells in the immunopathogenesis and therapy of liver diseases. Japanese Journal of Clinical Immunology 2004; 27(2): 64 doi: 10.2177/jsci.27.64
|
2 |
XUE‐ZHANG DUAN, HUI ZHUANG, MIN WANG, HAN‐WEI LI, JING‐CHAO LIU, FU‐SHENG WANG. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). Journal of Gastroenterology and Hepatology 2005; 20(2): 234 doi: 10.1111/j.1440-1746.2004.03529.x
|
3 |
Ke-Xia Wang, Jiang-Long Peng, Xue-Feng Wang, Ye Tian, Jian Wang, Chao-Pin Li. Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B. World Journal of Gastroenterology 2003; 9(9): 2017-2020 doi: 10.3748/wjg.v9.i9.2017
|
4 |
Ming-Qing Xu, Wei Wang, Lan Xue, Lv-Nan Yan. NF-κB activation and zinc finger protein A20 expression in mature dendritic cells derived from liver allografts undergoing acute rejection. World Journal of Gastroenterology 2003; 9(6): 1296-1301 doi: 10.3748/wjg.v9.i6.1296
|
5 |
Le H. Song, Vu Q. Binh, Dinh N. Duy, Jürgen F.J. Kun, Thomas C. Bock, Peter G. Kremsner, Adrian J.F. Luty. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. Journal of Clinical Virology 2003; 28(1): 93 doi: 10.1016/S1386-6532(02)00271-8
|
6 |
Weiwei Chen, Zheng Zhang, Ming Shi, Liangen Chen, Junliang Fu, Feng Shi, Bing Zhang, Hui Zhang, Lei Jin, Fu-Sheng Wang. Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response. Clinical Immunology 2008; 129(2): 295 doi: 10.1016/j.clim.2008.07.026
|
7 |
Ying Cai, Wenwei Yin. The Multiple Functions of B Cells in Chronic HBV Infection. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.582292
|
8 |
S Tavakoli, I Mederacke, S Herzog-Hauff, D Glebe, S Grün, D Strand, S Urban, A Gehring, P R Galle, W O Böcher. Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection. Clinical and Experimental Immunology 2007; 151(1): 61 doi: 10.1111/j.1365-2249.2007.03547.x
|
9 |
Kumar Visvanathan, Narelle A. Skinner, Alex J.V. Thompson, Stephen M. Riordan, Vitini Sozzi, Roslyn Edwards, Sally Rodgers, Jelica Kurtovic, Judy Chang, Sharon Lewin, Paul Desmond, Stephen Locarnini. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45(1): 102 doi: 10.1002/hep.21482
|
10 |
Antonio Bertoletti, Adam Gehring. Immune response and tolerance during chronic hepatitis B virus infection. Hepatology Research 2007; 37(s3) doi: 10.1111/j.1872-034X.2007.00221.x
|
11 |
Jingjiao Song, Sheng Li, Yun Zhou, Jia Liu, Sandra Francois, Mengji Lu, Dongliang Yang, Ulf Dittmer, Kathrin Sutter. Different antiviral effects of IFNα subtypes in a mouse model of HBV infection. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00469-1
|
12 |
Jun Hong, Zuo Jiong Gong. Human plasmacytoid dendritic cells from patients with chronic hepatitis B virus infection induce the generation of a higher proportion of CD4+ and CD25+ regulatory T cells compared with healthy patients. Hepatology Research 2008; 38(4): 362 doi: 10.1111/j.1872-034X.2007.00279.x
|
13 |
Jorge A. Soto, Nicolas M. S. Gálvez, Catalina A. Andrade, Gaspar A. Pacheco, Karen Bohmwald, Roslye V. Berrios, Susan M. Bueno, Alexis M. Kalergis. The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01513
|
14 |
Weiwei Chen, Ming Shi, Feng Shi, Yuanli Mao, Zirong Tang, Bin Zhang, Hui Zhang, Liangen Chen, Liming Chen, Shaojie Xin, Fu‐sheng Wang. HBcAg‐pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus‐specific cytotoxic T lymphocytes. Hepatology Research 2009; 39(4): 355 doi: 10.1111/j.1872-034X.2008.00468.x
|
15 |
Mingli Peng, Min Chen, Ning Ling, Hongmei Xu, Yuling Qing, Hong Ren. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70. Vaccine 2006; 24(7): 887 doi: 10.1016/j.vaccine.2005.12.050
|
16 |
Xue‐Zhang Duan, Hong‐Xia He, Hui Zhuang. Restoration in vitro of impaired T‐cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2). Journal of Gastroenterology and Hepatology 2006; 21(6): 970 doi: 10.1111/j.1440-1746.2006.04262.x
|
17 |
Daniel O Villarreal, Kendra T Talbott, Daniel K Choo, Devon J Shedlock, David B Weiner. Synthetic DNA vaccine strategies against persistent viral infections. Expert Review of Vaccines 2013; 12(5): 537 doi: 10.1586/erv.13.33
|
18 |
Sheng Guo, Chengying Yang, Feng Mei, Shengxi Wu, Na Luo, Lei Fei, Yongwen Chen, Yuzhang Wu. Down-regulation of Z39Ig on macrophages by IFN-γ in patients with chronic HBV infection. Clinical Immunology 2010; 136(2): 282 doi: 10.1016/j.clim.2010.03.007
|
19 |
Weixia Chen, Lei Wang, Yaofei Niu, Guang Ji, Lianjun Xing. Distribution of peripheral dendritic cells in patients with HBV infection or spleen and kidney deficiency. Journal of Medical Virology 2018; 90(4): 706 doi: 10.1002/jmv.24998
|
20 |
Anthony Tanoto Tan, Sarene Koh, Vera Goh, Antonio Bertoletti. Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective. Journal of Gastroenterology and Hepatology 2008; 23(6): 833 doi: 10.1111/j.1440-1746.2008.05385.x
|
21 |
Ming-Qing Xu, Yu-Ping Suo, Jian-Ping Gong, Ming-Man Zhang, Lü-Nan Yan. Prolongation of liver allograft survival by dendritic cells modified with NF-κB decoy oligodeoxynucleotides. World Journal of Gastroenterology 2004; 10(16): 2361-2368 doi: 10.3748/wjg.v10.i16.2361
|
22 |
Ping‐Wei Zhao, Fei‐Yong Jia, Yu‐Xing Shan, Hui‐Fan Ji, Jun‐Yan Feng, Jun‐Qi Niu, Desalegn A Ayana, Yan‐Fang Jiang. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir. Clinical and Experimental Pharmacology and Physiology 2013; 40(3): 190 doi: 10.1111/1440-1681.12048
|
23 |
Antonio Bertoletti, Carlo Ferrari. Kinetics of the Immune Response During Hbv and Hcv Infection. Hepatology 2003; 38(1): 4 doi: 10.1053/jhep.2003.50310
|
24 |
Ju Cao, Liping Zhang, Shifeng Huang, Pu Chen, Lin Zou, Hui Chen, Yu Xiang, Xiaofei Lai, Guosheng Ren. Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B. Microbial Pathogenesis 2011; 51(4): 262 doi: 10.1016/j.micpath.2011.06.003
|
25 |
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis B. World Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
|
26 |
A. Bertoletti. Pathogenesis and Clinical Practice in Gastroenterology. 2008; 160: 149 doi: 10.1007/978-1-4020-8767-7_15
|
27 |
Sk Md Fazle Akbar, Norio Horiike, Morikazu Onji. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World Journal of Gastroenterology 2006; 12(18): 2876-2883 doi: 10.3748/wjg.v12.i18.2876
|
28 |
|
29 |
Yanzhong Peng, Xiaojia Xiong, Xindeng Tong, Min Li, Xifei Yang, Guoxin Hu, Yijie Geng, Jianxin Li. Correlation of the content of hepatitis B core antigen in peripheral blood mononuclear cells with HBV virus load. Diagnostic Microbiology and Infectious Disease 2016; 85(2): 154 doi: 10.1016/j.diagmicrobio.2015.09.017
|
30 |
Yin Huang, Zhi Chen, Hongyu Jia, Wei Wu, Shigen Zhong, Cheng Zhou. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Clinical Immunology 2006; 119(3): 280 doi: 10.1016/j.clim.2006.01.015
|
31 |
Anita Schuch, Alexander Hoh, Robert Thimme. The Role of Natural Killer Cells and CD8+ T Cells in Hepatitis B Virus Infection. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00258
|
32 |
Zheng Zhang, Ji‐Yuan Zhang, Li‐Feng Wang, Fu‐Sheng Wang. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. Journal of Gastroenterology and Hepatology 2012; 27(2): 223 doi: 10.1111/j.1440-1746.2011.06940.x
|
33 |
Zhi-Hua Feng, Quan-Chu Wang, Qing-He Nie, Zhan-Sheng Jia, Yong-Xin Zhou. DC-SIGN: Binding receptor for HCV?. World Journal of Gastroenterology 2004; 10(7): 925-929 doi: 10.3748/wjg.v10.i7.925
|
34 |
XUE-ZHANG DUAN, MIN WANG, HAN-WEI LI, HUI ZHUANG, DONGPING XU, FU-SHENG WANG. Decreased Frequency and Function of Circulating Plasmocytoid Dendritic Cells (pDC) in Hepatitis B Virus Infected Humans. Journal of Clinical Immunology 2004; 24(6): 637 doi: 10.1007/s10875-004-6249-y
|
35 |
Allan Ma, Bruce Motyka, Klaus Gutfreund, Yuenian Eric Shi, Rajan George. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Human Vaccines & Immunotherapeutics 2020; 16(4): 756 doi: 10.1080/21645515.2019.1689080
|
36 |
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish. Drugs in Development for Hepatitis B. Drugs 2017; 77(12): 1263 doi: 10.1007/s40265-017-0769-2
|
37 |
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma. Journal of the Formosan Medical Association 2021; 120(8): 1581 doi: 10.1016/j.jfma.2020.11.015
|
38 |
Soheila Tavakoli, Wibke Schwerin, Andreas Rohwer, Sina Hoffmann, Sandra Weyer, Robert Weth, Helga Meisel, Helmut Diepolder, Michael Geissler, Peter R. Galle, Hanns F. Löhr, Wulf O. Böcher. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection.
Journal of General Virology
2004; 85(10): 2829 doi: 10.1099/vir.0.80143-0
|
39 |
Antonio Bertoletti, Adam Gehring. Therapeutic vaccination and novel strategies to treat chronic HBV infection. Expert Review of Gastroenterology & Hepatology 2009; 3(5): 561 doi: 10.1586/egh.09.48
|
40 |
Libin Jiang, Song Hu, Deying Tian, Xiaojing Zou, Man He. α-Mannosidase I Protein Expression in Peripheral Blood Mononuclear Cells Is Upregulated During Hepatitis B Virus Infection. Viral Immunology 2016; 29(1): 33 doi: 10.1089/vim.2015.0079
|
41 |
Ying Tang, Tianyi Ma, Shengnan Jia, Qian Zhang, Siqi Liu, Ling Qi, Lanlan Yang. The Mechanism of Interleukin-35 in Chronic Hepatitis B. Seminars in Liver Disease 2021; 41(04): 516 doi: 10.1055/s-0041-1731708
|
42 |
ZHENJUN YU, TING JIANG, MIN ZHU, KECHUAN PAN, FEI YAN, JIANSHENG ZHU. Effects of T cell immunoglobulin and mucin domain-containing molecule-3 signaling molecule on human monocyte-derived dendritic cells with hepatitis B virus surface antigen stimulation in vitro. Molecular Medicine Reports 2016; 13(3): 2785 doi: 10.3892/mmr.2016.4815
|
43 |
Jun Wu, Meihong Han, Jia Li, Xiaoli Yang, Dongliang Yang. Hepatitis B Virus Infection. Advances in Experimental Medicine and Biology 2020; 1179: 71 doi: 10.1007/978-981-13-9151-4_4
|
44 |
Malika Ait-goughoulte, Julie Lucifora, Fabien Zoulim, David Durantel. Innate Antiviral Immune Responses to Hepatitis B Virus. Viruses 2010; 2(7): 1394 doi: 10.3390/v2071394
|
45 |
João Panão Costa, Armando de Carvalho, Artur Paiva, Olga Borges. Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression. Pharmaceuticals 2024; 17(7): 964 doi: 10.3390/ph17070964
|
46 |
Antonio Bertoletti, Nikolai V Naoumov. Translation of immunological knowledge into better treatments of chronic hepatitis B. Journal of Hepatology 2003; 39(1): 115 doi: 10.1016/S0168-8278(03)00126-0
|
47 |
Amitis Ramezani, Mohammad Reza Hasanjani Roshan, Ebrahim Kalantar, Ali Eslamifar, Mohammad Banifazl, Jaleh Taeb, Arezoo Aghakhani, Latif Gachkar, Ali Akbar Velayati. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. Journal of Gastroenterology and Hepatology 2008; 23(11): 1716 doi: 10.1111/j.1440-1746.2008.05482.x
|
48 |
|
49 |
Chuan-Lin Ding, Kun Yao, Tian-Tai Zhang, Feng Zhou, Lin Xu, Jiang-Ying Xu. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells. World Journal of Gastroenterology 2003; 9(7): 1512-1515 doi: 10.3748/wjg.v9.i7.1512
|
50 |
Antonio Bertoletti, Adam J. Gehring. The immune response during hepatitis B virus infection. Journal of General Virology 2006; 87(6): 1439 doi: 10.1099/vir.0.81920-0
|
51 |
Antonio Bertoletti, Patrick Kennedy, Adam J. Gehring. Liver Immunology. 2007; : 179 doi: 10.1007/978-1-59745-518-3_15
|
52 |
Kazuto Tajiri, Yukihiro Shimizu. New horizon for radical cure of chronic hepatitis B virus infection. World Journal of Hepatology 2016; 8(21): 863-873 doi: 10.4254/wjh.v8.i21.863
|
53 |
Ye-Gui Jiang, Yu-Ming Wang, Tong-Hua Liu, Jun Liu. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World Journal of Gastroenterology 2003; 9(10): 2221-2225 doi: 10.3748/wjg.v9.i10.2221
|
54 |
Ming-Qing Xu, Zhen-Xiang Yao. Functional changes of dendritic cells derived from allogeneic partial liver graft undergoing acute rejection in rats. World Journal of Gastroenterology 2003; 9(1): 141-147 doi: 10.3748/wjg.v9.i1.141
|
55 |
Min Chen, Yong-Guo Li, Da-Zhi Zhang, Zhi-Yi Wang, Wei-Qun Zeng, Xiao-Feng Shi, Yuan Guo, Shu-Hua Guo, Hong Ren. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study. World Journal of Gastroenterology 2005; 11(12): 1806-1808 doi: 10.3748/wjg.v11.i12.1806
|
56 |
Yong-Sheng Yu, Zheng-Hao Tang, Jing-Chao Han, Min Xi, Jie Feng, Guo-Qing Zang. Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 α DCs induced in vivo by IFN-α in patients with chronic hepatitis B. World Journal of Gastroenterology 2006; 12(9): 1447-1451 doi: 10.3748/wjg.v12.i9.1447
|
57 |
Zhi-Qiang Zou, Li Wang, Kai Wang, Ji-Guang Yu. Innate immune targets of hepatitis B virus infection. World Journal of Hepatology 2016; 8(17): 716-725 doi: 10.4254/wjh.v8.i17.716
|
58 |
Qiuju Han, Peixiang Lan, Jian Zhang, Cai Zhang, Zhigang Tian. Reversal of hepatitis B virus‐induced systemic immune tolerance by intrinsic innate immune stimulation. Journal of Gastroenterology and Hepatology 2013; 28(S1): 132 doi: 10.1111/jgh.12034
|
59 |
Jin Luo, Jun Li, Rui L. Chen, Lei Nie, Jie Huang, Zheng W. Liu, Lin Luo, Xiao J. Yan. Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers. Vaccine 2010; 28(13): 2497 doi: 10.1016/j.vaccine.2010.01.038
|
60 |
Juliana Echevarria-Lima, Ramona Moles. Monocyte and Macrophage Functions in Oncogenic Viral Infections. Viruses 2024; 16(10): 1612 doi: 10.3390/v16101612
|
61 |
Qin Wang, Yanan Liu, Jinzhuo Luo, Shangqing Yang, Lu Wang, Yinping Lu, Xuemei Feng, Xuecheng Yang, Kathrin Sutter, Ulf Dittmer, Mengji Lu, Xin Zheng, Dongliang Yang, Jia Liu. A systematic comparison reveals dynamic differences in early adaptive immune responses of acute‐resolving versus chronic HBV replication. Journal of Medical Virology 2023; 95(3) doi: 10.1002/jmv.28670
|
62 |
Junyan Feng, Lu Lu, Cong Hua, Ling Qin, Pingwei Zhao, Juan Wang, Ye Wang, Wanyu Li, Xiaodong Shi, Yanfang Jiang, Clive M. Gray. High Frequency of CD4+CXCR5+ TFH Cells in Patients with Immune-Active Chronic Hepatitis B. PLoS ONE 2011; 6(7): e21698 doi: 10.1371/journal.pone.0021698
|
63 |
Li Wang, Kai Wang, Zhi-Qiang Zou. Crosstalk between innate and adaptive immunity in hepatitis B virus infection. World Journal of Hepatology 2015; 7(30): 2980-2991 doi: 10.4254/wjh.v7.i30.2980
|
64 |
N HYODO, I NAKAMURA, M IMAWARI. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clinical and Experimental Immunology 2004; 135(3): 462 doi: 10.1111/j.1365-2249.2003.02376.x
|
65 |
Yinping Lu, Yang Xu, Dongliang Yang, Thekla Kemper, Michael Roggendorf, Mengji Lu. Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes. Cytokine 2008; 41(2): 127 doi: 10.1016/j.cyto.2007.11.002
|
66 |
Antonio Bertoletti, Anthony T. Tan, Adam J. Gehring. HBV-Specific Adaptive Immunity. Viruses 2009; 1(2): 91 doi: 10.3390/v1020091
|
67 |
M Shi, S Qian, W-W Chen, H Zhang, B Zhang, Z-R Tang, Z Zhang, F-S Wang. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responsesin vitro. Clinical and Experimental Immunology 2007; 147(2): 277 doi: 10.1111/j.1365-2249.2006.03281.x
|
68 |
Yui-Jie Bai, Jin-Rong Zhao, Guan-Ting Lv, Wen-Hong Zhang, Yan Wang, Xiao-Jun Yan. Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization. World Journal of Gastroenterology 2003; 9(10): 2344-2347 doi: 10.3748/wjg.v9.i10.2344
|
69 |
Hadi Peeridogaheh, Zahra Meshkat, Shahram Habibzadeh, Mohsen Arzanlou, Jafar Mohammad Shahi, Sina Rostami, Sina Gerayli, Roghayeh Teimourpour. Current concepts on immunopathogenesis of hepatitis B virus infection. Virus Research 2018; 245: 29 doi: 10.1016/j.virusres.2017.12.007
|